0001826834-23-000002.txt : 20230809 0001826834-23-000002.hdr.sgml : 20230809 20230809131808 ACCESSION NUMBER: 0001826834-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 EFFECTIVENESS DATE: 20230809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biopharmaceutical Research Co CENTRAL INDEX KEY: 0001826834 IRS NUMBER: 820650107 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489227 FILM NUMBER: 231154384 BUSINESS ADDRESS: STREET 1: 11045 COMMERCIAL PARKWAY CITY: CASTROVILLE STATE: CA ZIP: 95012 BUSINESS PHONE: 831-632-0913 MAIL ADDRESS: STREET 1: 11045 COMMERCIAL PARKWAY CITY: CASTROVILLE STATE: CA ZIP: 95012 D 1 primary_doc.xml X0708 D LIVE 0001826834 Biopharmaceutical Research Co 11045 COMMERCIAL PARKWAY CASTROVILLE CA CALIFORNIA 95012 831-632-0913 DELAWARE Biopharmaceutical Research Company, LLC None Corporation true George Bennett Hodgin 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Executive Officer Director Charles Schumacher 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Director Osagie Imasogie 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Director David Weinmann 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Executive Officer Other Technology Decline to Disclose 06b false 2023-08-07 false true true true false 0 676065 676065 0 false 1 0 0 0 The warrant is being issued in full satisfaction of the Issuer's obligations to North Point Mergers and Acquisitions Inc. for advisory services in connection with the Issuer's Equity Private Placements. false Biopharmaceutical Research Co /S/ George Bennett Hodgin George Bennett Hodgin Chief Executive Officer 2023-08-09